Health Condition 1: J960- Acute respiratory failure
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Control Intervention1: NIL: NIL
Sponsors
CSIR Institute of Genomics and Integrative Biology IGIB
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients aged 18 years or older will be included as ARDS primarily affects adults 2 Diagnosis of ARDS Only patients diagnosed with ARDS according to the Berlin criteria with suspected or documented Pneumonia infection in blood sputum and or BAL culture will be included in the study 3 Consent Patients or their legally authorized representatives must provide informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1 Patients receiving corticosteroid treatment 2 Patients with chronic obstructive pulmonary disease asthma ILD Emphysema or IPF 3 Diabetic patients 4 Immunosuppressive Conditions 5 Patients with Platelet count less than 20000 per microlitre and INR less than one and half 6 Patients with lung cancer existing or with history of Tuberculosis 7 Patients who has gone through lung transplant 8 Patients with pulmonary hypertension 9 Patients with Fungal infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cytokine Profiling and Immune PhenotypesTimepoint: The day of Onset of ARDS | — |
Secondary
| Measure | Time frame |
|---|---|
| Elevated IRAK3 Expression in Immune Suppressive GroupTimepoint: The day of Onset of ARDS | — |
Countries
India
Contacts
Public ContactDr Deepak Govil
CSIR Institute of Genomics and Integrative Biology IGIB
Outcome results
None listed